Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 52

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 52
---
 differ materially from those expressed or implied in such forward-looking statements due to a variety of factors and risks,
including, but not limited to, those set forth under “Risk Factors” and “Our Company” set forth in this prospectus
and the documents incorporated herein by reference., and the following factors and risks:

| ● | our expectations of future revenues, expenditures, capital or other funding requirements;                                              |
| ● | the adequacy of our cash and working capital to fund present and planned operations and growth;                                        |
| ● | our business strategy and the timing of our expansion plans;                                                                           |
| ● | demand for Therapeutic DNA Production Services;                                                                                        |
| ● | demand for DNA Tagging Services;                                                                                                       |
| ● | demand for MDx Testing Services, including in light of significantly decreasing demand for COVID testing services;                     |
| ● | our ability to develop our MDx Testing Services business;                                                                              |
| ● | our expectations concerning existing or potential development and license agreements for third-party collaborations or joint ventures; |
| ● | regulatory approval and compliance for our Therapeutic DNA Production and MDx Testing Services;                                        |
| ● | the effect of governmental regulations generally;                                                                                      |
| ● | our expectations of when regulatory submissions may be filed or when regulatory approvals may be received;                             |
| ● | our expectations concerning product or service candidates for our technologies; and                                                    |
| ● | our expectations of when or if we will become profitable.                                                                              |

<div align='center'>4</div>

Any or all of our forward-looking statements may turn out
to be wrong. They may be affected by inaccurate assumptions that we might make or by known or unknown risks and uncertainties. Actual
outcomes and results may differ materially from what is expressed or implied in our forward-looking statements. Among the factors that
could affect future results are:

| ● | the inherent uncertainties of product and/or service development based on our new and as yet not fully proven technologies;                                                 |
| ● | the risks and uncertainties regarding the actual effect on humans and/or animals of seemingly safe and efficacious formulations and treatments when tested clinically;      |
| ● | the inherent uncertainties associated with clinical trials of product candidates;                                                                                           |
| ● | the inherent uncertainties associated with the process of obtaining regulatory clearance or approval to market product candidates and/or testing services;                  |
| ● | the inherent uncertainties associated with commercialization of products and/or services that have received regulatory clearance or approval;                               |
| ● | economic and industry conditions generally and in our